Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study (Q37295997)
Jump to navigation
Jump to search
scientific article published on 14 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study |
scientific article published on 14 July 2015 |
Statements
1 reference
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study (English)
1 reference
J Miyagawa
1 reference
M Odawara
1 reference
T Takamura
1 reference
N Iwamoto
1 reference
Y Takita
1 reference
T Imaoka
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference